Page 8 - Sartorius News Today

J. Keeler Johnson handicaps six graded stakes at Saratoga, including the Travers S. (G1).

Mechanicville native has Artorius, Zandon and Early Voting in the Grade I, $1.25 million...

Through its combined forces, Sartorius and Albumedix will accelerate the availability of critical components for the manufacture of advanced therapies and next-generation biopharmaceuticals

The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham,... | August 8, 2022

FRENCH PREVIEW: British raider looks good in Gheest 2022-08-06

After two G1 placings in the UK, the globetrotting Aussie sprinter will chase a win in France on Sunday

Pharmaceutical and biopharmaceutical companies are facing major challenges today: rising costs in drug production as well as lower production volumes due to unpredictable demand. Click to read more...

Son of Arrogate, the 2016 Travers winner, takes stakes race by 4 3/4 lengths.

DJ Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Information on Document Availability 21-Jul-2022 / 08:21 CET/CEST Dissemination

Stephen Yiu and Peter Hargreaves’ Blue Whale Growth fund fell 30% in the first half of 2022, as the fund’s favoured technology sector crashed.